Back
Ligand Pharmaceuticals 10K Form
Sell
48
LGND
Ligand Pharmaceuticals
Last Price:
82.65
Seasonality Move:
-2.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
2023-11-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
2023-08-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
2023-05-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
2022-11-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
2022-08-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
Receive LGND News And Ratings
See the #1 stock for the next 7 days that we like better than LGND
LGND Financial Statistics
Sales & Book Value
Annual Sales: | $131.31M |
---|---|
Cash Flow: | $16.18M |
Price / Cash Flow: | 0 |
Annual Sales: | $45.00 |
Price / Book: | 1.84 |
Profitability
EPS (TTM): | 5.32000 |
---|---|
Net Income (TTM): | $96.34M |
Gross Margin: | $120.8M |
Return on Equity: | 13.82% |
Return on Assets: | 11.93% |
Ligand Pharmaceuticals Earnings Forecast
Key Ligand Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 30 years for LGND is 91.99%.
- The Selling, General & Administrative Expenses for LGND have been equal to 40.20% of Gross Profit Margin.
- The Research & Development expenses have been 18.69% of Revenue.
- The Interest Expense is 1.26% of Operating Income.
- The Net Earning history of LGND is 39.72% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 19 years.
Ligand Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | LGND |
CUSIP: | 53220K |
Website: | ligand.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 20.7 |
Quick Ratio: | 19.03 |
Price-to-Earnings
Trailing P/E Ratio: | 28.13 |
---|---|
Forward P/E Ratio: | 14.92 |
LGND Technical Analysis vs Fundamental Analysis
Sell
48
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy or a Sell?
-
Ligand Pharmaceuticals stock is rated a Sell
The current Ligand Pharmaceuticals [LGND] share price is $82.70. The Score for LGND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.